Admera Health LLC

South Plainfield, NJ Part of Genewiz, LLC

UEI
WQN1JED965X5
CAGE
7BR03
Primary NAICS
541380 Testing Laboratories and Services
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
Corporate family
  • Genewiz, LLC Parent South Plainfield, NJ HAYFEH7AD428
    • Admera Health LLC
SAM.gov registration date
Physical address
126 Corporate Blvd, South Plainfield, NJ 07080, USA
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $3,727
FY2025 $152,147
FY2024 $84,531
FY2023 $44,746

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Commerce $7,797

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Admera Health LLC, a minority-owned small disadvantaged business based in South Plainfield, New Jersey, performs next-generation sequencing and RNA-seq analysis services as a prime contractor across federal research agencies, competing predominantly under Total Small Business set-asides and full-and-open purchase orders. The company is a child entity of Genewiz, LLC, a for-profit corporate parent, and holds a Federal Supply Schedule contract with the Department of Veterans Affairs for medical laboratory testing and analysis services.

Admera Health's capability portfolio centers on high-throughput DNA and RNA sequencing, library preparation, bioinformatics analysis, and metagenomic analysis of biological tissue samples. The company operates under NAICS codes spanning Testing Laboratories and Services (541380), Research and Development in Biotechnology (541714), and Medical Laboratories (621511). Representative work includes a $53.1 thousand purchase order from USDA's Agricultural Research Service Southeast Area for mRNA sequencing of 354 chicken tissue samples (awarded September 2025), a $29.988 thousand order from USDA's Plains Area for RNA-seq of 252 wheat samples supporting Fusarium head blight disease resistance research (September 2025), a $52 thousand order from USDA's Northeast Area for stereo sequencing services extending single-cell sequencing technology (September 2024), and a $19.08 thousand order from USDA's Northeast Area for RNA extraction and sequencing of 120 rainbow trout tissue samples (June 2025). Recent work also includes a $7.797 thousand purchase order from the National Oceanic and Atmospheric Administration for high-throughput DNA sequencing (3 lanes) issued September 2026.

Customer concentration is heavily weighted to USDA Agricultural Research Service, which accounts for 65% of award count through seven awards from the Northeast Area division alone totaling $139 thousand combined potential value. The Smithsonian Institution places the second-highest volume (4 awards, $96 thousand), while the Department of Veterans Affairs holds the largest single-award value at $225 thousand through Veterans Integrated Service Network 12. Over 75% of combined potential value flows from four customers: Veterans Affairs, USDA Northeast Area, the Smithsonian, and the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases. Across 26 prime awards, the vendor has served 13 distinct federal agencies. Awards are predominantly structured as Total Small Business set-asides, with several full-and-open purchase orders issued by the VA and USDA. Activity has accelerated from one or two awards annually in 2021 and 2023 to seven awards in 2025, though recent data shows only one award issued in 2026 to date. Combined potential value across all awards stands at $750 thousand, with $525 thousand obligated (70% realization rate). Only one award is set to complete within the next twenty-four months, carrying $8 thousand in potential value, indicating limited near-term recompete exposure.

Quick answers

Is Admera Health LLC registered in SAM.gov?

Yes. Admera Health LLC's SAM.gov registration is active through February 27, 2027.

Which contract vehicles does Admera Health LLC hold?

Admera Health LLC holds a place on 1 federal contract vehicle: FSS-621-II.

How much has Admera Health LLC received in federal contracts?

Federal contracts obligated $152,147 to Admera Health LLC in fiscal year 2025 and $285,151 in fiscal years 2023 through 2027.

How does Admera Health LLC rank among federal contractors?

Admera Health LLC ranked #99 in PSC B529 in FY2025.

What is Admera Health LLC's most recent federal award?

Admera Health LLC's most recent federal contract award is High throughput DNA sequencing service - 3 lanes (1305M326P0349), from National Oceanic and Atmospheric Administration, on September 11, 2026.

On GovTribe

See Admera Health LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors